These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7443732)

  • 1. Inhibition of neuroleptic-induced dopamine receptor supersensitivity by cyclo (Leu-Gly).
    Bhargava HN; Ritzmann RF
    Pharmacol Biochem Behav; 1980 Nov; 13(5):633-6. PubMed ID: 7443732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats.
    Bhargava HN
    Neuropharmacology; 1984 Apr; 23(4):439-44. PubMed ID: 6145116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cyclo(Leu-Gly) on the supersensitivity of dopamine receptors in spontaneously hypertensive rats.
    Bhargava HN
    Life Sci; 1983 May; 32(18):2131-7. PubMed ID: 6843287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phase.
    Bhargava HN
    Life Sci; 1984 Feb; 34(9):873-9. PubMed ID: 6142397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cyclo (Leu-Gly) on neurochemical indices of striatal dopaminergic supersensitivity induced by prolonged haloperidol treatment.
    Le Douarin C; Fage D; Scatton B
    Life Sci; 1984 Jan; 34(4):393-9. PubMed ID: 6694528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclo (Leu-Gly) + haloperidol: effects on dopamine receptors and conditioned avoidance responding.
    Bean AJ; Elgin RJ; Cooper DM; Martin GE
    Peptides; 1987; 8(1):39-44. PubMed ID: 3575153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cyclo (Leu-Gly) on chemical denervation supersensitivity of dopamine receptors induced by intracerebroventricular injection of 6-hydroxydopamine in mice.
    Ritzmann RF; Bhargava HN
    Life Sci; 1980 Dec; 27(22):2075-80. PubMed ID: 6782403
    [No Abstract]   [Full Text] [Related]  

  • 8. Blockage of narcotic-induced dopamine receptor supersensitivity by cyclo(Leu-Gly).
    Ritzmann RF; Walter R; Bhargava HN; Flexner LB
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5997-8. PubMed ID: 293696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of melanotrophin release inhibiting factor (MIF) and cyclo (Leu-Gly) on the tolerance to morphine-induced antinociception in the rat: a dose-response study.
    Bhargava HN
    Br J Pharmacol; 1981 Apr; 72(4):707-14. PubMed ID: 6116510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radio-frequency analysis of the effect of haloperidol and cyclo (leucyl-glycyl) on apomorphine-induced stereotypy.
    Fields JZ; Gonzalez LP; Meyerson LR; Lieber P; Lee JM; Steece KA; DeLeon-Jones FA; Ritzmann RF
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1279-84. PubMed ID: 3809231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of cyclo(leucyl-glycyl) on nigrostriatal dopaminergic supersensitivity--inhibition of apomorphine-induced climbing.
    Fields JZ; Lee JM; Gordon JH; Wichlinski LJ; Ritzmann RF
    Neuropeptides; 1990 Aug; 16(4):207-11. PubMed ID: 2274115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclo (Leu-Gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine.
    Lee JM; DeLeon-Jones F; Fields JZ; Ritzmann RF
    Alcohol Drug Res; 1987; 7(1):1-10. PubMed ID: 2431697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclo(Leu-Gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine: agonist binding to D2 dopamine receptors correlates with stereotypic behavior.
    Lee JM; Fields JZ; Ritzmann RF
    Life Sci; 1983; 33 Suppl 1():405-8. PubMed ID: 6229678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
    Pittman KJ; Jakubovic A; Fibiger HC
    Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclo(Leu-Gly): a possible treatment for tardive dyskinesia?
    Bhargava HN
    Mod Probl Pharmacopsychiatry; 1983; 21():196-205. PubMed ID: 6656783
    [No Abstract]   [Full Text] [Related]  

  • 16. Peptide inhibition of morphine-induced dopaminergic supersensitivity.
    Ritzmann RF; Lee JM; Fields JZ
    Life Sci; 1982 Nov 15-22; 31(20-21):2287-90. PubMed ID: 6891737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced response to apomorphine in rats treated with multiple injections of human beta endorphin and its blockade by Pro-Leu-Gly-NH2 and cyclo (Leu-Gly).
    Bhargava HN
    Life Sci; 1981 Nov; 29(19):1945-9. PubMed ID: 6118804
    [No Abstract]   [Full Text] [Related]  

  • 18. Implications of dopamine agonist-induced hypothermia following increased density of dopamine receptors in the mouse.
    Feigenbaum JJ; Yanai J
    Neuropharmacology; 1985 Aug; 24(8):735-41. PubMed ID: 3939327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclo(Leu-Gly) has opposite effects on D-2 dopamine receptors in different brain areas.
    Lee JM; Ritzmann RF; Fields JZ
    Peptides; 1984; 5(1):7-10. PubMed ID: 6231532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclo (leucylglycine) inhibits the development of morphine induced analgesic tolerance and dopamine receptor supersensitivity in rats.
    Bhargava HN
    Life Sci; 1980 Jul; 27(2):117-23. PubMed ID: 7190637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.